Viewing Study NCT01016769

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:55 PM
Ignite Modification Date: 2026-04-22 @ 9:43 PM
Study NCT ID: NCT01016769
Status: COMPLETED
Last Update Posted: 2019-06-26
First Post: 2009-11-18
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Squamous Cell Cancer View
None Head and Neck Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Paclitaxel View
None Carboplatin View
None Temsirolimus View
None Head and Neck View
None recurrent and/or metastatic View
None 09-131 View